Frank Bobe
Keine laufenden Positionen mehr
Profil
Frank Bobe served as President & Chief Executive Officer at SpringLeaf Therapeutics, Inc. from 2008 to 2011, and at BioAxone Therapeutic, Inc. from 2005 to 2007.
He also served as President & Chief Executive Officer at Seres Therapeutics, Inc. Additionally, he held the position of Chief Business Officer & Executive Vice President at Alseres Pharmaceuticals, Inc. from 2007 to 2009.
Prior to that, he worked at Novartis AG as a Principal from 1995 to 2005, and as General Manager at Novartis Korea Co., Ltd.
from 1999 to 2003.
He also served as Vice President at Novartis Pharmaceuticals Canada, Inc. from 2003 to 2004.
Bobe holds an MBA from INSEAD, a doctorate from the University of California, Davis, and an undergraduate degree from the University of Bielefeld.
Ehemalige bekannte Positionen von Frank Bobe
| Unternehmen | Position | Ende |
|---|---|---|
| ALSERES PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09.01.2009 |
BioAxone Therapeutic, Inc.
 BioAxone Therapeutic, Inc. Medical/Nursing ServicesHealth Services BioAxone Therapeutic, Inc. provides an experimental therapy for the treatment of neurological disorders. The company was founded in April 2000 by Pierre Caouette and Lisa Mckerracher and is headquartered in Montreal, Canada. | Vorstandsvorsitzender | 01.04.2007 |
| NOVARTIS AG | Corporate Officer/Principal | 01.03.2005 |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | 01.06.2004 |
Novartis Korea Co., Ltd.
 Novartis Korea Co., Ltd. Drugstore ChainsRetail Trade Novartis Korea Ltd. engages in the manufacture and sale of pharmaceutical products. The company was founded on September 20, 1984 and is headquartered in Seoul, South Korea. | Corporate Officer/Principal | 01.12.2003 |
Ausbildung von Frank Bobe
| University of California, Davis | Doctorate Degree |
| INSEAD | Masters Business Admin |
| University of Bielefeld | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALSERES PHARMACEUTICALS, INC. | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 4 |
|---|---|
BioAxone Therapeutic, Inc.
BioAxone Therapeutic, Inc. Medical/Nursing ServicesHealth Services BioAxone Therapeutic, Inc. provides an experimental therapy for the treatment of neurological disorders. The company was founded in April 2000 by Pierre Caouette and Lisa Mckerracher and is headquartered in Montreal, Canada. | Health Services |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |
SpringLeaf Therapeutics, Inc.
 SpringLeaf Therapeutics, Inc. Drugstore ChainsRetail Trade SpringLeaf Therapeutics, Inc. is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including Excel Venture Management, Flybridge Capital Partners, North Bridge Venture Partners and SR One. | Retail Trade |
Novartis Korea Co., Ltd.
Novartis Korea Co., Ltd. Drugstore ChainsRetail Trade Novartis Korea Ltd. engages in the manufacture and sale of pharmaceutical products. The company was founded on September 20, 1984 and is headquartered in Seoul, South Korea. | Retail Trade |
